Display search results for ** instead (83 products)

Showing 1-10 of 83

10 Jan 2020  |  Asia Pacific

Growth Insights on China’s Pharmaceutical Industry, Forecast to 2025

Expedited Regulatory Reviews, Accompanied by Surging Novel Drug Pipelines and a Realigned Distribution System will Propel the Chinese Pharma Industry

With over-4000 pharmaceutical players, China is the second largest pharmaceutical industry globally. Although highly fragmented, global pharma and biopharmaceutical players such as Novartis, Novo Nordisk, and AstraZeneca, have a significant hold capturing at least 8-10Percentage of the market. The market being highly dependent on its distributor ne...

USD 10,000.00
26 Feb 2020  |  Europe

Growth Opportunities from the Evolution of Electronic Health Record (EHR) in Europe, Forecast to 2024

Actionable Strategies and Tactics to Accelerate Growth in a Transforming Market

The healthcare IT landscape is witnessing rapid transformation as governments focus more on value-based care and preventive health programs to reduce the overall economic burden on health systems, along with increased efficiency in managing increasing patient populations. The basic Electronic Medical Record (EMR) is evolving into a more comprehensi...

USD 4,950.00
14 Feb 2020  |  Asia Pacific

Select Diagnostic Imaging Equipment Market Landscape in Malaysia, Forecast to 2023

New Budget Allocations, Expansions in Private Sector, and Time to Market on Next-generation Imaging Equipment Opens Up Robust Market Opportunities

This study presents an analysis of the Malaysian diagnostic imaging equipment market. It provides an in-depth analysis of the current trends, market size, and revenue forecast, and market penetration, market attractiveness, in digital radiography, ultrasound, computed tomography, magnetic resonance imaging, interventional X-ray, and fluoroscopy. M...

USD 4,950.00
20 Feb 2020  |  Europe

EU Healthcare Predictions and Outlook, 2020

Rise in Orphan Drug R&D Pipeline, AI-based Funding, and Growth in Biocontract Manufacturing to be Key Drivers of Growth

Amid rising global trade tensions and sluggish global economic outlook for 2020, the global healthcare market is expected to cross the 2-trillion-dollar mark in 2020. In Europe, BREXIT is likely to have a strong impact on the United Kingdom, Europe's biggest digital health market. 2020 will be a global reality check for long-pending national health...

USD 4,950.00
27 Jan 2020  |  Global

Growth Opportunities—Contract Manufacturing and Outsourcing Opportunities in the In-vitro Diagnostics (IVD) Industry, 2019 to 2022

Consolidation and Innovative Business Models Will Accelerate IVD Outsourcing Growth

The increasing pressure for cost-driven development and regulatory and regional trends are inducing industry participants to adopt innovative integrated business models so as to align themselves as one-stop-shop solution providers as opposed to the traditional functional service providers, thereby, creating a mutually beneficial symbiotic relations...

USD 4,950.00
28 Jan 2020  |  North America

Global Healthcare Cloud Computing Market, Forecast to 2023

Competitive Dynamics are Pushing Services to the Forefront

Cloud computing in healthcare is gaining momentum as a variety of factors create a significant need for the value propositions that a successful cloud implementation promises to offer. Global healthcare cloud market revenue is expected to surge at a compound annual growth rate of 25.1% from 2018 to 2023. Cloud computing involves the use of exter...

USD 4,950.00
05 May 2020  |  North America

FROST RADAR™: Artificial Intelligence for Drug Discovery in the Pharmaceutical Industry, 2020

Benchmarking Future Growth Potential

Pharmaceutical drug discovery and development suffers from declining success rates with new molecules and the rate of return shrinking from 16Percentage in 2011 to almost 11Percentage in 2018. Frost & Sullivan research indicates that traditional solutions that have focused primarily on data from limited sources and rule-based computational techniqu...

USD 4,950.00
30 Apr 2020  |  Asia Pacific

COVID-19—Implications for the Healthcare Industry, 2020

Winning Strategies and Key Opportunities that are Evolving During this Disruption

A team of futurists, analysts, and consultants from the Global Transformational Health Research Team at Frost & Sullivan have come together to render a comprehensive analysis to predict the future of healthcare with COVID-19 disruption in perspective. This study provides actionable predictions and growth opportunities for major healthcare segments ...

USD 4,950.00
29 Apr 2020  |  Global

Technology Breakthroughs Driving Allergy & Infectious Disease Therapy

Forthcoming and Available Therapies for Allergy, Infectious Diseases and COVID-19

The current research study discusses the available countermeasures and forthcoming allergic and infectious diseases. The most common allergic diseases such as allergic rhinitis, also know as Hay fever or seasonal allergies; sinusitis; asthma and chronic obstructive pulmonary disease (COPD); atopic dermatitis (or eczema); urticaria (or hives) and mo...

USD 4,950.00
11 May 2020  |  Asia Pacific

Outlook of India’s Healthcare Industry, 2020

Indian Healthcare Industry is Expected to Grow at 16.9% in 2020 to Reach $272.79 Billion in 2020

The study covers the healthcare market which develops and provides products, solutions, and/or services across the care spectrum for diagnosis, treatment, and prevention. The biosimilars market in India is expected to cross $0.9 billion by 2020. The growing prevalence of chronic diseases with an increasing aged population in India and globally, c...

USD 4,950.00

Showing 1-10 of 83